Navigation Links
HealthSaaS Inc. with iMPak Health and Meridian Health Announce Integrated Pain Management and Medication Adherence Solution

PORTLAND, Ore. and NEPTUNE, N.J., Jan. 11, 2012 /PRNewswire-iReach/ -- The iMPak Health Journal for Pain empowers patients to easily record their pain levels before and after their prescribed medication regimen, providing physicians with readily available, useful, patient information.  The Health Journal for Pain provides a consumer engaged method for date and time stamp pain levels and the impact of both long-acting and short medications not readily seen before.

About the size of a smart phone or credit card, iMPak Health products are daily journal device cards that capture health-related data and transmit the information wirelessly using a Near Field Communications (NFC) reader.

Using the HealthSaaS Connected Outcomes Platform patient data will be securely transmitted from a patient's home to health care providers. Physician-requested data can be viewed within graphical reports using HealthSaaS white-labeled provider portals and optionally into backend Electronic Health Record systems (EHRs). Data can also be viewed by patients, family members and caregivers using HealthSaaS patient portals.

"It is widely held that pain is considered the fifth vital sign. The pain journal not only helps track daily pain levels, but is a easy and powerful tool for determining a specific patient's response to their medication regimen," said Sandra Elliott Director of Consumer Technology and Service Development at Meridian Health, a not for profit health system in New Jersey that helped to create iMPak Health.

Frank Ille, CEO, of HealthSaaS said, "We are excited to announce this innovative alliance with iMPak because of the impact that it can make for elderly patients or others that are uncomfortable with computers, or who cannot afford expensive technology. Our collaboration with iMPak focusing on consistent monitoring of pain and medication adherence is an important aspect of any chronic pain management plan. This integrated solution can help improve clinical outcomes, reduce ER visits associated with over/under medicating and will decrease the overall costs associated with managing chronic pain."

"It is clear that both companies share a commitment to making it easy for the patient to engage in their own care," said Albert Baker Director at iMPak Health and VP of Strategic Relations at Cypak a Swedish based technology company that helped create iMPak Health. "A excellent patient experience is fundamental to providing excellent data for a effective outcome focused care system at large."

About HealthSaaS, Inc.
The HealthSaaS Connected Outcomes Platform is a cloud-based system designed to be interoperable with mHealth applications, cloud based services, Telehealth solutions and connected medical devices. This innovative Platform removes silo barriers and makes data available to clinician practices, provider networks, payers, self funded employers and EHR systems.

The HealthSaaS Connected Outcomes Platform is an FDA Class I Medical Device Data System. As an MDDS it is designed and developed in accordance with a quality system compliant with ISO13485 standards so it aligns with the quality requirements of U.S. and international regulatory agencies in the healthcare industry.

For more information, visit

About iMPak Health, L.L.C.
A joint venture of Swedish-based chip developer and innovator Cypak and Meridian Health, a not for profit leader, iMPak Health brings together the latest in wireless technology and the frontline know-how of today's health care environment to provide consumers and patients with effective and intuitive tools to better manage their health.  IMPak Health's mission is to become a leader in developing, easy-to-use devices to screen, diagnose, and monitor health conditions.

For more information, visit or follow us at @seimpakhealth.  

Media Contact: Frank Ille HealthSaaS, Inc., 503-459-9028,

News distributed by PR Newswire iReach:


SOURCE HealthSaaS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Tone Deafness Explained, from the Harvard Health Letter
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
8. ViroPharma to Present at Three Upcoming Healthcare Conferences
9. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
10. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
11. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
Post Your Comments:
(Date:6/26/2016)... , June 26, 2016 One of Australia,s ... announced the formation of a new biotechnology company, Noxopharm Limited [ABN ... in an IPO and to list on the ASX. ... NOX66, ready to enter a Phase 1 clinical study later this ... to address one of the biggest problems facing cancer patients - ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals plc ... period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, ... of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ... (Eastern Daylight Time). As previously announced on ... a definitive merger agreement under which Jazz Pharmaceuticals has ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... ... recently awarded their highest five-star rating to Best Buy Eyeglasses, an ... United States and Canada wear eyeglasses. Once considered to be a purely functional part ... fashion statement. Even celebrities use glasses as a way of creating an iconic image—like ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
Breaking Medicine News(10 mins):